278 related articles for article (PubMed ID: 15451497)
21. Efficacy and safety of colistin (colistimethate sodium) for therapy of infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii in Siriraj Hospital, Bangkok, Thailand.
Koomanachai P; Tiengrim S; Kiratisin P; Thamlikitkul V
Int J Infect Dis; 2007 Sep; 11(5):402-6. PubMed ID: 17291803
[TBL] [Abstract][Full Text] [Related]
22. Antimicrobial activity of tigecycline tested against organisms causing community-acquired respiratory tract infection and nosocomial pneumonia.
Fritsche TR; Sader HS; Stilwell MG; Dowzicky MJ; Jones RN
Diagn Microbiol Infect Dis; 2005 Jul; 52(3):187-93. PubMed ID: 16105563
[TBL] [Abstract][Full Text] [Related]
23. [Bacterial etiology of nosocomial pneumonia and antimicrobial resistance in patients with and without antimicrobial treatment].
Weyland B; Perazzi B; García S; Rodríguez C; Vay C; Famiglietti A
Rev Argent Microbiol; 2011; 43(1):18-23. PubMed ID: 21491061
[TBL] [Abstract][Full Text] [Related]
24. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO
Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562
[TBL] [Abstract][Full Text] [Related]
25. Polymyxins: older antibiotics for a new threat.
Lee SY; Kuti JL; Nicolau DP
Conn Med; 2006 Jan; 70(1):25-8. PubMed ID: 16479873
[TBL] [Abstract][Full Text] [Related]
26. Nebulized colistin in the treatment of pneumonia due to multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa.
Kwa AL; Loh C; Low JG; Kurup A; Tam VH
Clin Infect Dis; 2005 Sep; 41(5):754-7. PubMed ID: 16080101
[TBL] [Abstract][Full Text] [Related]
27. Challenges in identifying new antimicrobial agents effective for treating infections with Acinetobacter baumannii and Pseudomonas aeruginosa.
Rice LB
Clin Infect Dis; 2006 Sep; 43 Suppl 2():S100-5. PubMed ID: 16894511
[TBL] [Abstract][Full Text] [Related]
28. Epidemiological and resistance issues in multidrug-resistant staphylococci and enterococci.
Leclercq R
Clin Microbiol Infect; 2009 Mar; 15(3):224-31. PubMed ID: 19335370
[TBL] [Abstract][Full Text] [Related]
29. Prevalence and antibiotic susceptibility of Acinetobacter baumannii, Pseudomonas aeruginosa and Klebsiella pneumoniae in Estonian intensive care units in comparison with European data.
Lõivukene K; Sepp E; Adamson V; Mitt P; Kallandi U; Otter K; Naaber P
Scand J Infect Dis; 2006; 38(11-12):1001-8. PubMed ID: 17148068
[TBL] [Abstract][Full Text] [Related]
30. A Phase 3, open-label, non-comparative study of tigecycline in the treatment of patients with selected serious infections due to resistant Gram-negative organisms including Enterobacter species, Acinetobacter baumannii and Klebsiella pneumoniae.
Vasilev K; Reshedko G; Orasan R; Sanchez M; Teras J; Babinchak T; Dukart G; Cooper A; Dartois N; Gandjini H; Orrico R; Ellis-Grosse E;
J Antimicrob Chemother; 2008 Sep; 62 Suppl 1():i29-40. PubMed ID: 18684704
[TBL] [Abstract][Full Text] [Related]
31. Advances in the management of pneumonia in the intensive care unit: review of current thinking.
Rello J; Diaz E; Rodríguez A
Clin Microbiol Infect; 2005 Oct; 11 Suppl 5():30-8. PubMed ID: 16138817
[TBL] [Abstract][Full Text] [Related]
32. Clinical experience of tigecycline treatment in infections caused by extensively drug-resistant Acinetobacter spp.
Moon SY; Peck KR; Chang HH; Kim SW; Heo ST; Son JS; Ryu SY; Moon C; Jung SI; Shin SY; Lee JA; Joung MK; Chung DR; Kang CI; Song JH
Microb Drug Resist; 2012 Dec; 18(6):562-6. PubMed ID: 22775562
[TBL] [Abstract][Full Text] [Related]
33. Current review of antimicrobial treatment of nosocomial pneumonia caused by multidrug-resistant pathogens.
Jean SS; Hsueh PR
Expert Opin Pharmacother; 2011 Oct; 12(14):2145-8. PubMed ID: 21895553
[TBL] [Abstract][Full Text] [Related]
34. [Colistin use in ventilator-associated pneumonia due to panresistant Pseudomonas aeruginosa and Acinetobacter baumannii].
Taşbakan MS; Pullukçu H; Ekren PK; Oz AT; Midilli M; Aydemir S; Gürgün A; Başoğlu OK; Bacakoğlu F
Mikrobiyol Bul; 2009 Jan; 43(1):61-70. PubMed ID: 19334381
[TBL] [Abstract][Full Text] [Related]
35. Update on the main MDR pathogens: prevalence and treatment options.
Esposito S; De Simone G
Infez Med; 2017 Dec; 25(4):301-310. PubMed ID: 29286008
[TBL] [Abstract][Full Text] [Related]
36. Treatment of multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii pneumonia.
Falagas ME; Kasiakou SK; Michalopoulos A
J Cyst Fibros; 2005 May; 4(2):149-50. PubMed ID: 15886070
[No Abstract] [Full Text] [Related]
37. Stable carbapenem susceptibility rates among multidrug-resistant Acinetobacter spp. strains in a setting of high prevalence of carbapenem-resistant Pseudomonas aeruginosa.
Zavascki AP; Soares FC; Superti SV; Silbert S; Silva FM; Barth AL
Int J Antimicrob Agents; 2007 Aug; 30(2):187-9. PubMed ID: 17452093
[No Abstract] [Full Text] [Related]
38. Oxazolidinone susceptibility patterns for 2005: International Report from the Zyvox Annual Appraisal of Potency and Spectrum Study.
Ross JE; Fritsche TR; Sader HS; Jones RN
Int J Antimicrob Agents; 2007 Mar; 29(3):295-301. PubMed ID: 17239570
[TBL] [Abstract][Full Text] [Related]
39. The Microbiology of Bloodstream Infection: 20-Year Trends from the SENTRY Antimicrobial Surveillance Program.
Diekema DJ; Hsueh PR; Mendes RE; Pfaller MA; Rolston KV; Sader HS; Jones RN
Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 31010862
[TBL] [Abstract][Full Text] [Related]
40. [Successful treatment of a patient with multidrug resistant Acinetobacter baumannii meningitis with high dose ampicillin-sulbactam].
Sayin Kutlu S; Saçar S; Süzer T; Cevahir N; Okke D; Dirgen Caylak S; Turgut H
Mikrobiyol Bul; 2008 Apr; 42(2):353-8. PubMed ID: 18697435
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
